A Realistic Jynarque (Tolvaptan) Approval Scenario with Cigna in Washington (From Request to Yes)
Quick Answer: Getting Jynarque (Tolvaptan) Covered by Cigna in Washington
Path to approval: Submit Cigna prior authorization with documented rapid ADPKD progression (Mayo class 1C-1E or eGFR decline ≥3 mL/min/1.73m²/year), baseline labs, and REMS enrollment. If denied, file internal appeal within 180 days, then external review